Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*
2008 · Allergy · 4,669 citations
https://doi.org/10.1111/j.1398-9995.2007.01620.x
W
William W. Busse
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
935
Papers
63.7K
Citations
127
h-index
452
i10-index
William W. Busse is an academic researcher from University of Wisconsin–Madison. The author has contributed to research in topics: Asthma and respiratory diseases & Respiratory and Cough-Related Research & Allergic Rhinitis and Sensitization. The author has an h-index of 127, co-authored 795 publications.
ORCID: 0000-0003-2591-4696Papers by this author
worksBenralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
2016 · The Lancet · 1,338 citations
https://doi.org/10.1016/s0140-6736(16)31322-8
Exploring the Effects of Omalizumab in Allergic Asthma
2013 · American Journal of Respiratory and Critical Care Medicine · 881 citations
https://doi.org/10.1164/rccm.201208-1414oc
Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2
2020 · Journal of Allergy and Clinical Immunology · 585 citations
https://doi.org/10.1016/j.jaci.2020.04.009
Attitudes and actions of asthma patients on regular maintenance therapy: the INSPIRE study
2006 · BMC Pulmonary Medicine · 495 citations
https://doi.org/10.1186/1471-2466-6-13
Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study
2018 · The Journal of Allergy and Clinical Immunology In Practice · 273 citations
https://doi.org/10.1016/j.jaip.2018.04.043
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat